|
|
Reasons for differences |
As at December 31, 2020 |
Differences observed between accounting carrying value and amounts considered for regulatory purposes |
Net impact arising from Impairment (Stage 1,2 and 3) |
Fair Value Adjustment |
Effective Interest Rate (EIR) Adjustment |
Re-classification of Interest Receivable/ Payable and others |
Unamortised cost on staff loans (Day 1 difference) |
Other SLFRS Adjustments |
Tax Impact on SLFRS Adjustments |
|
Rs. '000 |
Rs. '000 |
Rs. '000 |
Rs. '000 |
Rs. '000 |
Rs. '000 |
Rs. '000 |
Rs. '000 |
Assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
83,794 |
(3,240) |
- |
- |
87,034 |
- |
- |
- |
Balances with Central Banks |
5,315 |
- |
- |
- |
5,315 |
- |
- |
- |
Placements with banks |
258,363 |
(3,003) |
- |
- |
261,366 |
- |
- |
- |
Derivative financial assets |
2,636,717 |
- |
- |
- |
2,636,717 |
- |
- |
- |
Financial assets at amortised cost -
Loans and advances to banks |
(85) |
(85) |
- |
- |
- |
- |
- |
- |
Financial assets at amortised cost -
Loans and advances to other customers |
(6,958,311) |
(13,313,309) |
- |
- |
11,320,359 |
(4,965,361) |
- |
- |
Financial assets at amortised cost -
Debt and other financial instruments |
(974,498) |
(1,956,020) |
- |
- |
981,522 |
- |
- |
- |
Financial assets measured at fair value through other comprehensive income |
(1,040,810) |
(1,041,777) |
- |
- |
967 |
- |
- |
- |
Property, plant and equipment and
right-of-use of assets |
4,761,737 |
- |
- |
- |
- |
- |
4,761,737 |
- |
Deferred tax assets |
2,499,860 |
- |
- |
- |
- |
- |
- |
2,499,860 |
Other assets |
(9,668,729) |
- |
- |
- |
(13,935,422) |
- |
4,266,693 |
- |
Liabilities |
|
|
|
|
|
|
|
|
Due to banks |
500,230 |
- |
- |
(29) |
500,259 |
- |
- |
- |
Derivative financial liabilities |
1,501,262 |
- |
- |
- |
1,501,262 |
- |
- |
- |
Securities sold under repurchase agreements |
(2,155) |
- |
- |
(2,155) |
- |
- |
- |
- |
Financial liabilities at amortised cost - due to depositors |
20,705,754 |
- |
- |
(515,612) |
21,221,366 |
- |
- |
- |
Financial liabilities at amortised cost - other borrowings |
121,526 |
- |
- |
- |
121,526 |
- |
- |
- |
Current tax liabilities |
(258,909) |
- |
- |
- |
- |
- |
- |
(258,909) |
Deferred tax liabilities |
(3,604,138) |
- |
- |
- |
- |
- |
- |
(3,604,138) |
Other liabilities |
(17,676,803) |
5,386,720 |
- |
- |
(23,063,523) |
- |
- |
- |
Subordinated liabilities |
1,070,181 |
- |
- |
(6,779) |
1,076,960 |
- |
- |
- |
Shareholders' equity |
|
|
|
|
|
|
|
|
Retained earnings |
(11,215,925) |
(17,646,073) |
- |
524,575 |
- |
- |
(1,980,268) |
7,885,841 |
Accumulated other comprehensive income |
462,330 |
- |
462,330 |
- |
- |
- |
- |
- |
Explanations of Differences between Accounting and Regulatory Exposure Amounts
Under SLFRS 9: "Financial Instruments: Recognition & Measurement", the Bank assess the impairment of loans and advances individually or collectively based on the principles of "expected credit loss" (Refer Note 18 for details) model which is expected to capture future trends in the economy. However, the regulatory provisions are made on loans and advances under the Direction No. 03 of 2008 on "Classification of loans and advances, Income Recognition and Provisioning" (and subsequent amendments thereof) issued by the CBSL are "time/delinquency base". Further, under SLFRS 9, other debt financial assets not held at FVTPL, together with loan commitments and other off balance sheet exposures such as financial guarantees and letter of credits, are subjected to impairment provision, whereas no such regulatory provision is required for those financial assets as per the CBSL Direction. As a result, SLFRS 9 recognises higher impairment provisions compared to CBSL guidelines.
Financial investments and financial liabilities (other than FVTPL) are carried at "cost" for regulatory reporting purposes while they are classified as "Financial assets measured at fair value through other comprehensive income" carried at fair value or Financial assets/liabilities at amortised cost under SLFRS 9. The "Fair value" is defined as the best estimate of the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date. A variety of valuation techniques combined with the range of plausible market parameters as at a given point in time may still generate unexpected uncertainty beyond fair value. An "amortised cost" of a financial asset or financial liability is the amount at which the financial asset or liability is measured at initial recognition, minus principal repayments, plus or minus the cumulative amortisation using the EIR method of any difference between theinitial amount recognised and the maturity amount, minus any reduction for impairment. Hence, the amortised cost of financial investments and financial liabilities under SLFRS 9 is different to the carrying value for regulatory reporting which is the "cost".
As per SLFRS 9, a "Day 1 difference" is recognised, when the transaction price differs from the fair value of other observable current market transactions in the same instrument. Eg: Employee below market loans. Refer Note 7.1.2.1 for details. However, the carrying value
of such transactions for regulatory reporting purposes is equal to cost/transaction price.
As per SLFRS 16, the Bank recognises a lease liability for leases previously classified as operating leases. Accordingly, the Bank measures the lease liability at the present value of the remaining lease payments, discounted using the Incremental Borrowing Rate (IBR). In addition, the Bank recognises right-of-use asset at an amount equal to the lease liability, on a lease-by-lease basis, adjusted by the amount of any prepaid or accrued lease payments relating to that lease. However as per regulatory reporting, the Bank charges the operating lease rentals as expense to profit or loss on an accrual basis.